Voloridge Investment Management
EDIT icon

Voloridge Investment Management’s Editas Medicine EDIT Stock Holding History

Voloridge Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,414
Closed -$307K – 1243
2024
Q1 		$307K Sell
41,414
-513,983
-93% -$4.27M ﹤0.01% 1089
2023
Q4 		$5.63M Buy
+555,397
New +$4.88M 0.02% 589
2023
Q3 		– Sell
-407,001
Closed -$3.35M – 1442
2023
Q2 		$3.35M Buy
407,001
+192,692
+90% +$1.68M 0.02% 817
2023
Q1 		$1.55M Buy
+214,309
New +$1.91M 0.01% 1039
2022
Q3 		– Sell
-452,140
Closed -$5.35M – 1443
2022
Q2 		$5.35M Sell
452,140
-289,376
-39% -$3.88M 0.03% 647
2022
Q1 		$14.1M Buy
741,516
+72,756
+11% +$1.35M 0.08% 325
2021
Q4 		$17.8M Buy
668,760
+254,096
+61% +$8.75M 0.1% 296
2021
Q3 		$17M Buy
414,664
+200,853
+94% +$11M 0.11% 251
2021
Q2 		$12.1M Sell
213,811
-60,470
-22% -$2.23M 0.08% 335
2021
Q1 		$11.5M Sell
274,281
-131,545
-32% -$7.49M 0.08% 316
2020
Q4 		$28.5M Buy
+405,826
New +$16.7M 0.24% 97
2020
Q1 		– Sell
-34,624
Closed -$1.02M – 1157
2019
Q4 		$1.02M Buy
+34,624
New +$865K 0.02% 650

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Voloridge Investment Management's EDIT Position: Q2 2024 in Review

Voloridge Investment Management sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 41,414 shares — an estimated $307K sold.

Voloridge Investment Management first reported a position in EDIT in Q4 2019 and held it in 12 quarters. The position peaked at $28.5M in Q4 2020. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Voloridge Investment Management reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 41,414 Editas Medicine shares in Q2 2024, an estimated $307K.
  • Voloridge Investment Management first reported a position in Editas Medicine in Q4 2019 and held it in 12 quarters.
  • Voloridge Investment Management's Editas Medicine position peaked at $28.5M in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.